Ador Multiproducts

Mumbai, India Founded: 1948 • Age: 78 yrs Listed
Personal care products are manufactured and supplied by Ador Multiproducts.

About Ador Multiproducts

Ador Multiproducts is a publicly listed company based in Mumbai (India) founded in 1948. Personal care products are manufactured and supplied by Ador Multiproducts. The company has 7 employees. Its Indian entity Thrive Future Habitats Limited reported revenue of β‚Ή2.33 Cr. Ador Multiproducts offers products and services including Sublime Life, Cocomo, Anatomicals, Booth & Berkeley, and Santic. Its focus areas include Retail, Contract Manufacturers, FMCG and Cosmetics. Its competitors include Primacy Industries, Influx Healthtech and Stella Indusstries; 1 of its 3 listed competitors has raised funding.

Company details

Ador Multiproducts was founded in 1948 and operates in the personal care sector. Skin care items, hygiene products such as hand sanitizers, and both alcohol-based and herbal options are produced and supplied. Contract manufacturing services are provided from facilities located in Bengaluru and Pondicherry, with headquarters in Mumbai, India.

  • Headquarters Mumbai, India
  • Employees 7
  • Stage Public
  • Sectors
    Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website adormultiproducts.com
  • Social LinkedIn
  • Legal Name Ador Multiproducts Ltd.
Key Metrics
  • Market Cap
    ₹91.69 Cr

    THRIVE · BSE

  • Share Price
    ₹84.90

    +4.81% today

  • Revenue
    ₹1.23 Cr

    FY 2025-26 · -43.6% YoY

  • EBITDA
    −₹1.77 Cr

    Margin -143.9%

  • Net Profit
    −₹2.06 Cr

    FY 2025-26 · -398.6% YoY

  • Debt / Equity
    0.02

    Interest cover -7.6x

  • Employee Count
    7

Products & Services of Ador Multiproducts

Ador Multiproducts offers a comprehensive portfolio of products and services, including Sublime Life, Cocomo, Anatomicals, Booth & Berkeley, and Santic.

Sublime Life
Online Beauty Platform

Online curation of clean and safe beauty brands.

Cocomo
Personal Care Products

Hand-crafted cleansers and lotions for children.

Anatomicals
Bath and Body Products

Paraben-free toiletries manufactured in India.

Booth & Berkeley
Grooming Essentials

Men's grooming products from head to toe.

Santic
Cleaning Solutions

Hygiene products for home and community use.

Funding Insights of Ador Multiproducts

  • Total Rounds 1

All 1 funding rounds of Ador Multiproducts with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2020Post-IPO––
–

Board of directors of Thrive Future Habitats Limited (Ador Multiproducts)

Thrive Future Habitats Limited is the primary company behind Ador Multiproducts. The board of Thrive Future Habitats Limited currently have 4 directors; the longest-serving is Sandeep Ahuja, appointed in 2025. 20 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sandeep Ahuja
DIN 00043118
Director20 Mar 20251 yr 7 moThrive Future Habitats Limited
Arvinder Singh Pasricha
DIN 00032420
Director27 May 20251 yr 4 moThrive Future Habitats Limited
Vinay Kumar Singh
DIN 06497700
Managing Director27 May 20251 yr 4 moThrive Future Habitats Limited
Praveen Kumari Singh
DIN 11096754
Director27 May 20251 yr 4 moThrive Future Habitats Limited

People of Ador Multiproducts

3 people are tracked at Ador Multiproducts (3 in leadership); the tracked headcount is 7.

NameRoleGroup
Aruna Advani
ChairmanLeadership
Ninotchka Malkani Nagpal
ChairmanLeadership
Ravin Mirchandani
Executive ChairmanLeadership
Premium access

Complete people profiles for Ador Multiproducts

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Ador Multiproducts

Ador Multiproducts is a publicly listed company on the BSE with ticker symbol ADORMUL in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date26 Aug 2002
  • Listed onBSE: 523120
  • Listed entityAdor Multiproducts Ltd.
  • Exchange sectorConsumer non-durables
  • ISININE628D01014
  • Share price₹135.60 (+4.99% on the day) · 2025-12-10
  • Market capitalisation₹123 Cr
  • EPS (diluted, trailing year)₹-7.42
  • Volume (last session)6,294
  • Analyst consensusNeutral

Financials of Ador Multiproducts

Exchange-reported figures of Thrive Future Habitats Limited, the listed company behind Ador Multiproducts (BSE: THRIVE).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹1.23 Cr
-43.6% YoY
EBITDA
−₹1.77 Cr
+46.2% YoY
Profit After Tax
−₹2.06 Cr
-398.6% YoY
Net Worth
₹52.72 Cr
+481.9% YoY
Total Assets
₹46.05 Cr
+1521.5% YoY
Total Debt
₹0.28 Cr
-59.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1.232.186.7312.1713.4419.349.87
Revenue growth-43.6%-67.6%-44.7%-9.5%-30.5%+96.0%-
EBITDA(1.77)(3.29)(7.93)(8.52)(6.36)(1.08)(3.10)
EBITDA margin-143.9%-150.9%-117.8%-70.0%-47.3%-5.6%-31.4%
Profit before tax(1.03)(3.20)(3.32)(9.05)(6.80)2.54(3.20)
Net profit(2.06)0.69(4.07)(9.11)(6.93)(1.42)(2.86)
Net profit margin-167.5%+31.7%-60.5%-74.9%-51.6%-7.3%-29.0%
EPS (β‚Ή)(0.90)(4.25)(9.79)(19.49)(14.83)3.20(7.20)
Balance sheet
Total assets46.052.845.299.1317.7213.8610.48
Net worth52.729.0611.0315.2220.7413.467.83
Total debt0.280.690.000.060.092.584.23
Cash & bank22.170.000.070.064.411.021.20
Net working capital22.970.491.52(0.26)7.714.602.77
Cash flow
Cash from operations(3.36)0.170.87(6.76)(8.85)(7.06)(3.68)
Cash from investing(18.31)0.180.230.19(0.90)4.193.18
Cash from financing43.84(0.42)(0.03)0.3612.912.691.09
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.350.470.080.370.300.660.630.22
Revenue growth (YoY)+16.7%-28.8%-87.3%+68.2%-55.2%---
Other income0.600.300.750.010.010.100.010.23
EBITDA(1.33)(1.00)(0.19)(0.38)(0.24)(2.92)(0.04)(0.15)
EBITDA margin-380.0%-212.8%-237.5%-102.7%-80.0%-449.2%-6.3%-68.2%
Depreciation0.110.080.040.050.040.130.130.20
Interest0.090.090.010.010.010.020.020.03
Profit before tax(0.93)(0.87)0.51(0.43)(0.28)(2.97)(0.18)(0.15)
Tax(0.01)(0.18)0.170.000.00(0.02)0.000.00
Net profit(0.92)(0.69)0.34(0.43)(0.28)(2.95)(0.18)(0.15)
EPS (β‚Ή)(0.45)(0.40)0.36(0.44)(0.30)(6.32)(0.39)(0.31)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1.222.185.155.897.2117.578.26
Revenue growth-44.0%-57.7%-12.6%-18.3%-59.0%+112.7%-
EBITDA(1.71)(0.48)(10.24)(1.60)(0.62)1.95(0.41)
EBITDA margin-140.2%-22.0%-198.8%-27.2%-8.6%+11.1%-5.0%
Profit before tax(0.99)(0.68)(10.51)(1.98)(0.64)6.05(0.43)
Net profit(0.98)(0.60)(0.74)(1.97)(0.77)1.73(0.08)
Net profit margin-80.3%-27.5%-14.4%-33.5%-10.7%+9.9%-1.0%
EPS (β‚Ή)(0.86)(1.39)(22.42)(4.21)(1.64)10.72(0.20)
Balance sheet
Total assets46.082.823.7514.3815.4716.119.44
Net worth45.762.062.7013.1715.1415.897.75
Total debt0.280.691.021.120.230.001.50
Cash & bank22.170.000.020.040.190.800.87
Net working capital22.990.471.261.892.694.552.95
Cash flow
Cash from operations(3.39)0.22(9.67)(0.98)0.18(4.13)(0.94)
Cash from investing(18.29)0.189.930.02(0.89)0.960.46
Cash from financing43.84(0.42)(0.18)(0.07)(0.13)3.090.75
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.350.470.080.370.300.660.630.22
Revenue growth (YoY)+16.7%-28.8%-87.3%+68.2%-55.2%---
Other income0.600.280.750.030.010.090.010.05
Total expenses1.651.410.270.740.540.800.670.36
EBITDA(1.30)(0.94)(0.19)(0.37)(0.24)(0.14)(0.04)(0.14)
EBITDA margin-371.4%-200.0%-237.5%-100.0%-80.0%-21.5%-6.3%-63.6%
Depreciation0.110.080.040.040.040.060.060.06
Interest0.090.090.010.010.010.020.020.03
Profit before tax(0.90)(0.83)0.51(0.39)(0.28)(0.13)(0.11)(0.18)
Tax(0.01)(0.18)0.170.000.000.190.000.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 25 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.350.470.080.370.300.660.630.22
Revenue growth (YoY)+16.7%-28.8%-87.3%+68.2%-55.2%---
Other income0.600.300.750.010.010.100.010.23
EBITDA(1.33)(1.00)(0.19)(0.38)(0.24)(2.92)(0.04)(0.15)
EBITDA margin-380.0%-212.8%-237.5%-102.7%-80.0%-449.2%-6.3%-68.2%
Depreciation0.110.080.040.050.040.130.130.20
Interest0.090.090.010.010.010.020.020.03
Profit before tax(0.93)(0.87)0.51(0.43)(0.28)(2.97)(0.18)(0.15)
Tax(0.01)(0.18)0.170.000.00(0.02)0.000.00
Net profit(0.92)(0.69)0.34(0.43)(0.28)(2.95)(0.18)(0.15)
EPS (β‚Ή)(0.45)(0.40)0.36(0.44)(0.30)(6.32)(0.39)(0.31)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1.232.186.7312.1713.4419.349.87
Revenue growth-43.6%-67.6%-44.7%-9.5%-30.5%+96.0%-
Other income1.100.795.440.310.304.270.54
Total expenses3.005.4714.6620.6919.8020.4212.97
Employee cost0.910.451.073.102.752.392.13
EBITDA(1.77)(3.29)(7.93)(8.52)(6.36)(1.08)(3.10)
EBITDA margin-143.9%-150.9%-117.8%-70.0%-47.3%-5.6%-31.4%
Depreciation0.210.600.530.690.430.360.26
Interest0.150.100.300.150.310.290.38
Profit before tax(1.03)(3.20)(3.32)(9.05)(6.80)2.54(3.20)
Tax(0.01)(0.03)0.710.060.131.04(0.34)
Net profit(2.06)0.69(4.07)(9.11)(6.93)(1.42)(2.86)
Net profit margin-167.5%+31.7%-60.5%-74.9%-51.6%-7.3%-29.0%
EPS (β‚Ή)(0.90)(4.25)(9.79)(19.49)(14.83)3.20(7.20)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital11.324.674.674.674.674.673.96
Reserves & surplus34.094.396.3610.5516.078.793.87
Shareholders' funds (net worth)52.729.0611.0315.2220.7413.467.83
Minority interest(7.00)(6.97)(5.78)(6.46)(3.37)(2.52)(1.88)
Secured loans0.000.690.000.000.002.583.74
Unsecured loans0.280.000.000.060.090.000.49
Total debt0.280.690.000.060.092.584.23
Total liabilities46.052.845.299.1317.7213.8610.48
Assets
Gross block5.304.286.3710.9810.889.429.72
Net block2.601.793.338.168.747.686.77
Capital work in progress0.000.000.000.000.000.000.00
Investments19.160.540.610.620.610.860.13
Inventories0.851.011.775.305.454.743.94
Sundry debtors0.040.130.191.321.611.882.48
Cash & bank balances22.170.000.070.064.411.021.20
Loans & advances0.400.022.142.842.342.031.57
Total current assets23.461.164.179.5213.819.679.19
Total current liabilities0.490.672.659.786.105.076.42
Net working capital22.970.491.52(0.26)7.714.602.77
Total assets46.052.845.299.1317.7213.8610.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.000.07(2.02)4.181.021.200.61
Net cash from operating activities(3.36)0.170.87(6.76)(8.85)(7.06)(3.68)
Net cash from investing activities(18.31)0.180.230.19(0.90)4.193.18
Net cash from financing activities43.84(0.42)(0.03)0.3612.912.691.09
Net change in cash22.16(0.07)1.08(6.20)3.16(0.18)0.59
Closing cash22.170.000.070.064.411.021.20
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-43.6%-67.6%-44.7%-9.5%-30.5%+96.0%-
EBITDA growth+46.2%+58.5%+6.9%-34.0%-488.9%+65.2%-
PBT growth+67.8%+3.6%+63.3%-33.1%-+9998.0%-133.6%
Net income growth-398.6%+117.0%+55.3%-31.5%-388.0%+50.4%-
Revenue CAGR (3Y)-53.4%-45.5%-29.7%+7.2%+22.7%+43.3%+13.8%
EBITDA CAGR (3Y)-40.8%-19.7%+94.4%+40.1%+70.6%+11.0%+32.9%
Profitability & leverage
Net income margin-82.9%-145.4%-59.9%-74.9%-51.6%+7.8%-29.0%
Return on capital employed0.0%0.0%0.0%0.0%0.0%-7.9%0.0%
Return on net worth0.0%0.0%0.0%0.0%0.0%-13.3%0.0%
Debt / equity0.020.030.000.000.080.320.36
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-7.58-2.57-3.55-1.63-4.57-20.14-11.31
Efficiency & per share
Fixed asset turnover0.260.410.781.111.322.021.34
Inventory turnover1.321.571.902.262.644.463.84
Debtors turnover14.4713.638.918.317.708.875.21
EPS (β‚Ή)(0.90)(4.25)(9.79)(19.49)(14.83)3.20(7.20)
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)40.1219.3923.6232.5744.3828.8119.76
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.350.470.080.370.300.660.630.22
Revenue growth (YoY)+16.7%-28.8%-87.3%+68.2%-55.2%---
Other income0.600.280.750.030.010.090.010.05
Total expenses1.651.410.270.740.540.800.670.36
EBITDA(1.30)(0.94)(0.19)(0.37)(0.24)(0.14)(0.04)(0.14)
EBITDA margin-371.4%-200.0%-237.5%-100.0%-80.0%-21.5%-6.3%-63.6%
Depreciation0.110.080.040.040.040.060.060.06
Interest0.090.090.010.010.010.020.020.03
Profit before tax(0.90)(0.83)0.51(0.39)(0.28)(0.13)(0.11)(0.18)
Tax(0.01)(0.18)0.170.000.000.190.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1.222.185.155.897.2117.578.26
Revenue growth-44.0%-57.7%-12.6%-18.3%-59.0%+112.7%-
Other income1.080.160.160.030.304.440.31
Total expenses2.932.6615.397.497.8315.628.67
Employee cost0.910.450.450.910.961.361.08
EBITDA(1.71)(0.48)(10.24)(1.60)(0.62)1.95(0.41)
EBITDA margin-140.2%-22.0%-198.8%-27.2%-8.6%+11.1%-5.0%
Depreciation0.210.260.290.300.290.280.20
Interest0.150.100.140.110.030.060.13
Profit before tax(0.99)(0.68)(10.51)(1.98)(0.64)6.05(0.43)
Tax(0.01)(0.03)(0.03)(0.01)0.131.04(0.35)
Net profit(0.98)(0.60)(0.74)(1.97)(0.77)1.73(0.08)
Net profit margin-80.3%-27.5%-14.4%-33.5%-10.7%+9.9%-1.0%
EPS (β‚Ή)(0.86)(1.39)(22.42)(4.21)(1.64)10.72(0.20)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital11.324.674.674.674.674.673.96
Reserves & surplus27.13(2.61)(1.97)8.5010.4711.223.79
Shareholders' funds (net worth)45.762.062.7013.1715.1415.897.75
Secured loans0.000.691.021.120.230.001.50
Unsecured loans0.280.000.000.000.000.000.00
Total debt0.280.691.021.120.230.001.50
Total liabilities46.082.823.7514.3815.4716.119.44
Assets
Gross block5.304.274.274.274.264.225.17
Net block2.601.782.042.332.622.832.49
Capital work in progress0.000.000.000.000.000.000.00
Investments19.160.540.6110.3710.378.874.11
Inventories0.851.011.772.502.823.063.20
Sundry debtors0.040.130.191.071.141.482.13
Cash & bank balances22.170.000.020.040.190.800.87
Loans & advances0.420.000.200.290.412.551.76
Total current assets23.481.142.183.904.567.897.96
Total current liabilities0.490.670.922.011.873.345.01
Net working capital22.990.471.261.892.694.552.95
Total assets46.082.823.7514.3815.4716.119.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.000.02(1.08)(0.05)0.800.870.61
Net cash from operating activities(3.39)0.22(9.67)(0.98)0.18(4.13)(0.94)
Net cash from investing activities(18.29)0.189.930.02(0.89)0.960.46
Net cash from financing activities43.84(0.42)(0.18)(0.07)(0.13)3.090.75
Net change in cash22.17(0.02)0.08(1.03)(0.85)(0.07)0.26
Closing cash22.170.000.020.040.190.800.87
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-44.0%-57.7%-12.6%-18.3%-59.0%+112.7%-
EBITDA growth-256.3%+95.3%-540.0%-158.1%-131.8%+575.6%-
PBT growth-45.6%+93.5%-430.8%-209.4%-+9998.0%+68.6%
Net income growth-63.3%+18.9%+62.4%-155.8%-144.5%+2262.5%-
Revenue CAGR (3Y)-40.8%-32.9%-33.6%-10.7%-0.3%+38.8%+8.0%
EBITDA CAGR (3Y)+2.2%-8.2%-+57.4%-21.5%--22.2%
Profitability & leverage
Net income margin-80.3%-29.8%-203.5%-33.5%-10.7%+28.5%-1.0%
Return on capital employed0.0%0.0%0.0%-12.5%-3.9%+16.8%0.0%
Return on net worth0.0%0.0%0.0%-13.9%-5.0%+14.6%0.0%
Debt / equity0.020.360.130.050.010.060.14
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-7.81-13.51-1.33-5.79-3.303.59-21.31
Efficiency & per share
Fixed asset turnover0.250.511.211.381.703.741.63
Inventory turnover1.311.572.412.212.455.613.75
Debtors turnover14.3513.638.175.335.509.734.80
EPS (β‚Ή)(0.86)(1.39)(22.42)(4.21)(1.64)10.72(0.20)
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)33.964.425.7928.1832.3934.0119.56

Timeline of Ador Multiproducts

3 dated milestones of Ador Multiproducts across 72 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ador Multiproducts is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round.

Competitors of Ador Multiproducts

Ador Multiproducts has 3 listed competitors in our database, 1 of them funded. They include Primacy Industries, Influx Healthtech and Stella Indusstries.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
primacyind.com2005Mangaluru, India$41.05M618
Scented candles, air, personal care, and hygiene products are contract-manufactured.
influxhealthtech.com2003Mumbai, India160
Contract based manufacturer of healthcare products
stella-indusstries.com1983Gurugram, India91
Produces high-quality personal care products, including aerosols and cosmetics.
Premium access

Detailed competitors of Ador Multiproducts

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Contract & Outsourced Manufacturing

3 companies that operate in the same segment as Ador Multiproducts (Contract & Outsourced Manufacturing) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Industrial components, mould bases, and storage solutions are manufactured globally.
1986Coimbatore, Tamil Nadu, IndiaUSD 28 MUSD 853.09 M3,060
Single- and three-phase transformers are manufactured in Mumbai.
1993Mumbai, Maharashtra, IndiaUSD 114.37 M618
Apparel and clothing are manufactured and exported on contract.
1979Bengaluru, Karnataka, IndiaUSD 400 M40,280
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ador Multiproducts

Premium access

Complete news archive for Ador Multiproducts

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ador Multiproducts

Ador Multiproducts was founded in 1948 and raised its 1st funding round 72 years after it was founded.

Ador Multiproducts is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Ador Multiproducts has 7 employees.

The primary company behind Ador Multiproducts, Thrive Future Habitats Limited, reported revenue of β‚Ή2.33 Cr for FY 2026, down 44% year on year.

Ador Multiproducts was founded in 1948 and operates in the personal care sector. Skin care items, hygiene products such as hand sanitizers, and both alcohol-based and herbal options are produced and supplied. Contract manufacturing services are provided from facilities located in Bengaluru and Pondicherry, with headquarters in Mumbai, India.

Ador Multiproducts's top competitors include Influx Healthtech, Stella Indusstries and Primacy Industries.

Ador Multiproducts offers Sublime Life, Cocomo, Anatomicals, Booth & Berkeley, and Santic.

Yes, Ador Multiproducts is publicly traded on BSE under the ticker symbol ADORMUL.

Ador Multiproducts operates through Thrive Future Habitats Limited.

The legal entities of Ador Multiproducts currently have 5 directors, including Sandeep Ahuja, Pinki Sharma, Arvinder Singh Pasricha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available